Key result
Circulating microRNAs show different expression levels in patients with and without coronary artery disease, suggesting their potential as minimally invasive biomarkers for diagnosis and prognosis.
Why the study?
To review circulating microRNA of blood plasma and serum and evaluate their potential as biomarkers of CAD at various stages.
Are circulating microRNAs useful as biomarkers for the diagnosis and prognosis of coronary artery disease?
Are circulating microRNAs useful as biomarkers for the diagnosis and prognosis of coronary artery disease?
Circulating microRNAs show promise as minimally invasive biomarkers for the diagnosis and prognosis of coronary artery disease.
No takes yet. Share an insight, caveat, or question.
May support microRNA profiling for CAD diagnosis; leaves open prospective validation before clinical adoption.
Mikhailina et al. (2025) conducted a review in Coronary artery disease. Circulating microRNA was evaluated. Circulating microRNAs show different expression levels in patients with and without coronary artery disease, suggesting their potential as minimally invasive biomarkers for diagnosis and prognosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: